The Risk and Time Course for Autoimmune Rheumatic Disease Development in Patients With Raynaud Phenomenon

Affiliations

• ¹ S. Teaw, MD, Department of Internal Medicine, University of Washington, Seattle, Washington, USA.
• ² A. Shojaee, MD, CHDA, Independent researcher, New Haven, Connecticut, USA.
• ³ M. Carnaru, MD, MS, University of Connecticut School of Medicine, Farmington, Connecticut, USA; Department of Internal Medicine, Section of Rheumatology, Allergy & Immunology, Yale School of Medicine, New Haven, Connecticut, USA.
• ⁴ M. Hinchcliff, MD, MS, Department of Internal Medicine, Section of Rheumatology, Allergy & Immunology, Yale School of Medicine, New Haven, Connecticut, USA.